A detailed history of ETF Managers Group, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 39,005 shares of VXRT stock, worth $22,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,005
Previous 32,722 19.2%
Holding current value
$22,622
Previous $31,000 6.45%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$0.71 - $1.25 $4,460 - $7,853
6,283 Added 19.2%
39,005 $29,000
Q4 2022

Mar 23, 2023

SELL
$0.75 - $2.24 $3,456 - $10,324
-4,609 Reduced 12.35%
32,722 $31,000
Q3 2022

Nov 14, 2022

SELL
$2.09 - $4.5 $5,471 - $11,781
-2,618 Reduced 6.55%
37,331 $81,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $5.28 $4,824 - $9,435
1,787 Added 4.68%
39,949 $141,000
Q1 2022

May 13, 2022

BUY
$4.29 - $6.64 $1,265 - $1,958
295 Added 0.78%
38,162 $190,000
Q4 2021

Feb 14, 2022

SELL
$5.77 - $7.96 $35,023 - $48,317
-6,070 Reduced 13.82%
37,867 $244,000
Q3 2021

Nov 15, 2021

BUY
$6.67 - $9.8 $52,466 - $77,086
7,866 Added 21.81%
43,937 $352,000
Q2 2021

Aug 16, 2021

SELL
$5.06 - $10.78 $96 - $204
-19 Reduced 0.05%
36,071 $298,000
Q1 2021

May 17, 2021

SELL
$5.64 - $23.33 $96,754 - $400,226
-17,155 Reduced 32.22%
36,090 $209,000
Q4 2020

Feb 16, 2021

SELL
$3.5 - $7.98 $28,301 - $64,526
-8,086 Reduced 13.18%
53,245 $318,000
Q3 2020

Nov 16, 2020

BUY
$4.78 - $16.97 $186,615 - $662,525
39,041 Added 175.15%
61,331 $419,000
Q2 2020

Aug 14, 2020

BUY
$1.68 - $8.85 $37,447 - $197,266
22,290 New
22,290 $167,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.